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Many bacterial pathogens utilize the 2-C-methyl-D-
erythritol 4-phosphate pathway for biosynthesizing
isoprenoid precursors, a pathway that is vital for
bacterial survival and absent from human cells, pro-
viding a potential source of drug targets. How-
ever, the characterization of 4-diphosphocytidyl-2-
C-methyl-D-erythritol (CDP-ME) kinase (IspE) has
been hindered due to a lack of enantiopure CDP-
ME and difficulty in obtaining pure IspE. Here, enan-
tiopure CDP-ME was chemically synthesized and
recombinant IspE from bacterial pathogens were
purified and characterized. Although gene disruption
was not possible in Mycobacterium tuberculosis,
IspE is essential in Mycobacterium smegmatis. The
biochemical and kinetic characteristics of IspE pro-
vide the basis for development of a high throughput
screen and structural characterization.INTRODUCTION
Isoprenoids are one of the largest groups of natural products,
including 35,000 primary and secondary metabolites (Chang
and Keasling, 2006; Hunter, 2007). Despite functional and struc-
tural diversity, all isoprenoids are derived from isopentenyl
diphosphate (IPP) and dimethylallyl diphosphate (DMAPP),
produced by the 2-C-methyl-D-erythritol 4-phosphate (MEP)
pathway in most bacterial pathogens, including Mycobacterium
tuberculosis (tuberculosis), Burkholderia mallei (glanders), Sal-
monella enterica serovar typhimurium (S. Typhi; typhoid fever),
and Vibrio cholerae (cholera). The early steps in the biosynthesis
of bacterial isoprenoids have been demonstrated to be essential
in both Gram-positive and Gram-negative bacteria (Brown and
Parish, 2008; Buetow et al., 2007; Cornish et al., 2006; Eoh
et al., 2007; Freiberg et al., 2001; Sauret-Gueto et al., 2003)
and the MEP pathway is not present in mammalian cells. Thus,
the MEP pathway is considered to be a good source of poten-
tial drug targets (Rohmer, 1998; Eoh et al., 2009; Testa and
Brown, 2003).1230 Chemistry & Biology 16, 1230–1239, December 24, 2009 ª2009The fourth enzyme in the MEP pathway (4-diphosphocytidyl-
2-C-methyl-D-erythritol [CDP-ME] kinase, IspE, EC2.7.1.148)
was first identified in Escherichia coli (Luttgen et al., 2000)
and tomato (Rohdich et al., 2000). IspE catalyzes the conversion
of CDP-ME to 4-diphosphocytidyl-2-C-methyl-D-erythritol-2-
phosphate (CDP-ME2P) in an ATP-dependent manner (Figure 1)
(Eoh et al., 2009; Luttgen et al., 2000). Even though sequence
alignments and crystal structures (Miallau et al., 2003) showed
that bacterial IspE has a high level of similarity to the ATP-depen-
dent GHMP kinase superfamily (Andreassi and Leyh, 2004;
Romanowski et al., 2002; Yang et al., 2002; Zhou et al., 2000),
which includes galactose kinase, homoserine kinase, mevalo-
nate kinase, and phosphomevalonate kinase, significant differ-
ences in the catalytic and substrate binding sites were observed,
suggesting that bacterial IspE may be a potential drug target
(Miallau et al., 2003; Eoh et al., 2009; Sgraja et al., 2008).
However, characterization of IspE from bacteria pathogenic to
humans has been hampered due to the lack of a source of enan-
tiopure CDP-ME and difficulties encountered in purification of
IspE from pathogenic species (Sgraja et al., 2008). Although
in silico studies indicate that the putative M. tuberculosis IspE
(Rv1011) has no predicted transmembrane domains and is
cytosolic, previous attempts to purify the native form of IspE
from M. tuberculosis failed (Sgraja et al., 2008). Purification of
recombinantM. tuberculosis IspE was made possible by gener-
ating genetically truncated proteins. Of eight truncated versions
of M. tuberculosis IspE generated, one showed kinetic proper-
ties similar to those obtained using native cytosolic protein
isolated from wild-type M. tuberculosis H37Rv. The truncation
strategy also allowed purification of recombinant IspE enzymes
from B. mallei, S. Typhi, and V. cholerae. In the present study,
we provide direct evidence of IspE essentiality inMycobacterium
smegmatis using allelic disruption (Jackson et al., 2000; Pan
et al., 2001). In addition, enantiopure CDP-ME was chemically
synthesized, improving the methods we previously reported for
chemo-enzymatic synthesis (Narayanasamy et al., 2008), and
recombinant IspE from pathogens with potential to be utilized
as agents of bioterrorism (Clarke, 2005; Pappas et al., 2006)
(M. tuberculosis, B. mallei, S. Typhi, and V. cholerae) was
purified.
The elucidation of the biochemical and kinetic properties of
IspE from human pathogens provides the groundwork forElsevier Ltd All rights reserved
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Figure 1. The MEP Pathway and the Reaction Catalyzed by IspE
Starting with pyruvate and glyceraldehyde 3-phosphate (GAP), the sequential
activities of DXS, IspC, and IspD produce CDP-ME, the substrate of IspE. IspE
phosphorylates the tertiary hydroxyl group of CDP-ME forming CDP-ME2P.
The reaction catalyzed by IspE is indicated by the dotted box. Abbreviations;
DXS, 1-deoxy-D-xylulose 5-phosphate synthase; IspC, 1-deoxy-D-xylulose 5-
phosphate reductoisomerase; IspD, 4-diphosphocytidyl-2-C-methyl-D-eryth-
ritol synthase; IspE, 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase; IspF,
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase; IspG, 1-hydroxyl-
2-methyl-2(E)-butenyl 4-diphosphate synthase; IspH, 1-hydroxy-2-methyl-
2(E)-butenyl 4-diphosphate reductase; CDP-ME, 4-diphosphocytidyl-2-C-
methyl-D-erythritol; CDP-ME2P, CDP-ME 2 phosphate; IPP, isopentenyl
diphosphate; DMAPP, dimethylallyl diphosphate.
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CDP-ME Kinase from Bacterial Pathogensdevelopment of high-throughput screening (HTS) assays and,
potentially, identification of novel antimicrobials.RESULTS
Synthesis of Enantiopure CDP-ME
Although the synthetic scheme of 3 from 1 is identical to
a previous report (Narayanasamy et al., 2008, Figure 2), several
steps for synthesizing enantiopure MEP were improved over
that report. At first, the tertiary hydroxyl group 3 was protected
by benzyl bromide, after treating 3 with KH to yield 90% of 4.Chemistry & Biology 16, 1230–123In this step, KH was found to be faster and better than NaH (Nar-
ayanasamy et al., 2008). The aldehyde 5 was reduced with
sodium borohydride forming benzyl-protected MEP precursor
6, which after hydrogenolysis with Pd/C in water/methanol
medium and without acid workup led to enantiopure MEP, which
was characterized by 1H-NMR, mass spectrometry (MS), and
optical rotation. The optical rotations of 3, 4, and 6 are newly
identified as +33.0, +13.0, and +10.0, respectively (Experimental
Procedures and Supplemental Data). Freshly preparedMEPwas
coupled with cytidine 50-monophosphate (CMP), which was
titrated with triethyl amine leading to the formation of corre-
sponding triethylammonium CMP. The phosphoester moiety
was activated by trifuoroacetic anhydride followed by conver-
sion to phosphoramide by treatment with methylimidazole and
then coupled with the tributylammonium salt of MEP. The crude
material was purified to obtain CDP-ME. Enantiopure intermedi-
ates and CDP-ME were confirmed by 1H-NMR and high-resolu-
tion MS (Experimental Procedures and Supplemental Data and
Figure S2). The methyl group at the 2 position of MEP moiety
in CDP-ME was observed as a singlet at 1.10 ppm and the cyti-
dine terminus was observed as a doublet at both 7.94 and
6.09 ppm (Rohdich et al., 2000; Cassera et al., 2004; Richard
et al., 2001). Optical rotation of the enantiopure CDP-ME was
found to be +13.7 in water. Thus enantiopure MEP was synthe-
sized and the coupling reaction of MEP with CMP was satisfac-
tory, yielding enantiopure CDP-ME.
Determination of Mycobacterial IspE Essentiality
Using M. smegmatis
An allelic disruption strategy was employed to show M. smeg-
matis MSMEG_5436 essentiality as previously described (Jack-
son et al., 2000). The pPR27::SM ispE::KanR plasmid has a
temperature-sensitive mycobacterial origin of replication that
facilitates recombination generating a single homologous-
recombination event at the M. smegmatis MSMEG_5436 locus.
The plasmid also harbors the sacB counter selectable marker
(Pelicic et al., 1997) and the xylE marker (Curcic et al., 1994).
Plasmid pPR27::SM ispE::KanR was electroporated into
M. smegmatis mc2155, and transformants were selected on LB
plates containing 30 mg/ml kanamycin (Kan) at 32C. One trans-
formant was then propagated in LB broth containing 30 mg/ml
Kan at 32C and plated onto LB plates containing 30 mg/ml Kan
at 42C. The temperature-sensitive origin containing pPR27::SM
ispE::KanR is not able to replicate at 42C and the Kan-resistant
colonies have necessarily integrated part or all of the plasmid
into M. smegmatis mc2155 chromosome, yielding single-cross-
over strains. The resulting colonies were analyzed for their XylE
phenotype with catechol (Pan et al., 2001) and yellow colonies
were further used. Double-crossover events were generated
by plating a total of 30 yellow, single-crossover strains onto LB
plates containing 30 mg/ml Kan and sucrose at 42C, leading
to the disruption of the M. smegmatis MESG_5436 gene; no
colonies were observed, suggesting that M. smegmatis
MSMEG_5436 is essential for M. smegmatis normal growth.
To confirm the essentiality of the gene, a rescue plasmid
(pCG76::SM ispE) was prepared and electroporated into the
single-crossover strains prior to generation of the double cross-
over. The single-crossover strains containing pCG76::SM ispE
were grown in LB broth containing 30 mg/ml Kan at 32C and9, December 24, 2009 ª2009 Elsevier Ltd All rights reserved 1231
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Figure 2. Synthetic Scheme of Enantiopure
CDP-ME
Enantiopure 2-C-methyl-D-erythritol 4-phosphate
(MEP) was synthesized from commercially avail-
able 1,2-O-isopropylidene-a-D-xylofuranose 1.
Subsequently, MEP is coupled with CMP to give
a 45% yield of pure CDP-ME.
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CDP-ME Kinase from Bacterial Pathogensthen plated onto LB plates containing 30 mg/ml Kan and sucrose
at 32C. The resulting colonies were analyzed for their XylE
phenotype with catechol (Pan et al., 2001), and a total of 30 white
colonies were obtained as the double-crossover strains. The
double-crossover strains were confirmed by polymerase chain
reaction (PCR) by using primer sets (MutSmispE-F and R)
(Table S3; data not shown). As a final experiment to confirm
that M. smegmatis MSMEG_5436 is essential for growth,
M. smegmatis double-crossover strains containing pCG76::SM
ispE were shown to be unable to grow at 42C (Figure 3B), due
to loss of the plasmid and its insert. On the other hand,M. smeg-
matis double-crossover strains containing pCG76::SM ispE
were shown to be able to grow at 32C and M. smegmatis
wild-type strains grew normally at both 32C and 42C. The
similar results were observed on the LB plates containing
30 mg/ml Kan (Figure 3C).
Identification of Putative IspE from M. tuberculosis,
B. mallei, S. Typhi, and V. cholerae
The putativeM. tuberculosis, B. mallei, S. Typhi, and V. cholerae
IspE proteins have 22%, 44%, 90%, and 59% identity with E. coli
IspE (Luttgen et al., 2000), respectively. All reported crucial
domains, including the glycine–rich domains and substrate
binding motifs of the E. coli ortholog (Luttgen et al., 2000;
Miallau et al., 2003), are well conserved in all IspE orthologs
(Figure 4A).
Purification of Active and Soluble Recombinant IspE
Although M. tuberculosis IspE is predicted to be cytosolic, puri-
fication of soluble, active IspE in native form proved difficult. To
facilitate the purification of reasonable quantities of M. tubercu-
losis IspE, eight truncated versions of IspE (Rv1011 I through
Rv1011 VIII) were cloned, expressed, and purified (Figure 4B).
M. tuberculosis IspE contains two predicted functional motifs;
a homoserine kinase (ThrB) motif and a GHMP kinase motif (Fig-
ure 4B); thus, sequences of the genetic constructs were based
on the motif distribution (for example, Rv1011 IV corresponds
to the ThrB motif and Rv1011 VIII, the smallest fragment, corre-
sponds to the GHMP kinase motif). The solubility of all of the1232 Chemistry & Biology 16, 1230–1239, December 24, 2009 ª2009 Elsevier Ltd All rights reexpressed proteins was dramatically
improved compared with that of intact
Rv1011, giving yields of 1 mg purified
protein per liter of culture. Of the ex-
pressed proteins, only Rv1011 I (D301-
305), Rv1011 II (D268-365), and Rv1011
IV showed IspE activity; the other
5 Rv1011 fragments were inactive under
the conditions tested. Rv1011 I showed
the greatest catalytic activity (Figure 4C).Rv1011 IV, containing only the ThrB and GHMP kinase domains,
showed very weak IspE activity and the activity of Rv1011 II,
missing C terminus of ThrB motif was intermediate. Therefore,
recombinant Rv1011 I was used for further characterization.
The three IspE orthologs from B. mallei, S. Typhi, and V. chol-
erae are also predicted to be cytosolic and the native forms also
proved difficult to express as soluble, active protein; however, as
for the M. tuberculosis IspE, enzymes from B. mallei, S. Typhi,
and V. cholerae could be expressed and purified after truncation
of the C-terminal five amino acids, again resulting in yields of
1 mg purified protein per liter of culture. Three truncated
versions of bacterial IspE enzymes of B. mallei, S. Typhi, and
V. cholerae were designated mBME, mSTE, and mVCE. The
induction and expression of Rv1011 I, mBME, mSTE and
mVCEwas confirmed by western blot analysis with the expected
molecular weights of 30.8, 31.4, 30.2, and 31.3 kDa, respectively
(Figure S4).
In Vitro Reaction Requirements of IspE Orthologs
The activities of purified Rv1011 I, mBME, mSTE, and mVCE
used in this study were linear with increasing protein up to at
least 194.8, 190.9, 198.5, 191.6 pmol, respectively, and all reac-
tions were linear with time up to 30 min. In order to confirm the
nature of the product, assay themixtures were incubated, lyoph-
ilized, dissolved in 100 mM aq. ammonium bicarbonate and
subjected to size exclusion chromatography on Bio-Gel P-2
gel fine columns eluted with 100 mM aq. ammonium bicar-
bonate; fractions containing putative product were then sub-
jected to further chromatography on benzyl DEAE cellulose
anion exchange columns, eluted using a gradient of 0- 0.5 M
aq. ammonium bicarbonate, and subsequent analysis by MS
revealed a peak at 633 m/z corresponding to [M+2NH4]
+.
The optimal pH and divalent cation concentrations for all
four IspE orthologs were determined. Rv1011 I was active over
a broad pH range (6.0 to 9.0), with optimal activity at pH 7.0 (Fig-
ure 5A). The pH optima for mBME, mSTE, and mVCE were
similar to that of Rv1011 I, although the pH range at which
Rv1011 I was active was somewhat narrower than those of the
other three IspE orthologs (Figure S5). Optimal activity forserved
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Figure 3. Essentiality of M. smegmatis IspE for the Bacterial Growth
(A) Schematic diagram of showing recombination in M. smegmatis mc2155. Black boxes indicate coding sequence of IspE (MSMEG_5436). Hatched regions
represent the intragenic DNA fragment replaced with a Kanamycin (Kan) resistant cassette (KanR) from pUC4K. For generation of MSMEG_5436 disrupted
KanR construct, KanR was cloned into RsrII sites of MSMEG_5436 and ligated with pPR27 yielding pPR27::Sm ispE::KanR. After homologous recombination,
selection for Kan resistance, sucrose resistance and xylE phenotype resulted in colonies with a disrupted MSMEG_5436, only in the presence of rescue vector
pCG76::Sm ispE, which contains temperature sensitive origin of replication and heat shock protein 60 promoter (Phsp60) shown in light grey.
(B) Growth curves ofM. smegmatismc2155 strains at 32 and 42C.M. smegmatismc2155 containing a rescue plasmid pCG76::Sm ispE at 32C (solid circles) or
at 42C (open circles),M. smegmatismc2155 wild-type at 32C (solid triangles) or at 42C (open triangles). All cultures were grown in LB broth containing appro-
priate antibiotics (See Experimental Procedures).
(C) Growth patterns ofM. smegmatis mc2155 double-crossover strains containing pCG76::Sm ispE at 32C (left) and 42C (right) on LB plates with appropriate
antibiotics.
Chemistry & Biology
CDP-ME Kinase from Bacterial PathogensmBME, mSTE, and mVCE was observed at pH 8.0, 8.0, and 7.5,
respectively.
The activity of Rv1011 I is absolutely dependent on the pres-
ence of divalent cations (Figure 5B), the addition of 5 mM
EDTA to the reaction mixture completely abolished the activity.
The activity of Rv1011 I was optimal in the presence of 6 mM
Mg2+. Other divalent cations including Mn2+, Ca2+, or Zn2+ sup-
ported little or no synthesis of CDP-ME2P at any concentration
tested (Figure 5B). Similar results were observed when mBME,
mSTE, and mVCE were tested (Figure S3).
Kinetic Properties of the IspE Orthologs
Reaction mixtures containing enantiopure CDP-ME, MgCl2,
[g-32P]ATP, and IspE generated a single radioactive product
with an Rf value of 0.13 was subjected to thin-layer chromatog-
raphy (TLC) analysis (Figure 6A); this product corresponds to
CDP-ME2P (Kishida et al., 2003; Testa et al., 2006). The
apparent Km
CDP–ME and Km
ATP for wild-type M. tuberculosis
H37Rv (in a crude cytosolic preparation) were calculated to be
206.7 ± 12.5 mM and 20.7 ± 1.2 mM, respectively. The Km
CDP–ME
andKm
ATP for purified Rv1011 I (97.2 pmol) were calculated to be
327.8 ± 21.4 mM and 75.2 ± 0.9 mM, respectively (Table 1). The
Km
CDP–ME values of mBME, mSTE, and mVCE were 31.3 ± 1.5,
25.4 ± 0.8, and 52.9 ± 11.7 mM, respectively, in the presence
of 100 mM ATP. The Km
ATP values of mBME, mSTE, and mVCEChemistry & Biology 16, 1230–123were 76.6 ± 1.1, 9.1 ± 0.2, and 8.8 ± 1.3 mM, respectively, in the
presence of 100 mM CDP-ME. The calculated kcat and kcat/Km
values are summarized in Table 1.Determination of Z0–Factor Values
The kinetic data determined above were used to develop a fluo-
rescence-based in vitro assay that is amenable to HTS. In this
assay, the release of ATP is coupled to pyruvate kinase, pyruvate
oxidase, and horseradish peroxidase, to produce a fluorescent
dye (resorufin) that can be measured spectrophotometrically
and is proportional to IspE catalytic activity. The Z0-Factor values
for the spectrophotometry based in vitro assay were calculated
based on 96 negative controls (without enzyme) and 96 positive
controls (with enzyme) in microplates using the equation:
Z0-Factor value = 1

3spositive  3snegative

jmpositive  mnegativej
where s represents the standard deviation and m is the mean
of each set of data points (Zhang et al., 1999). The Z0-Factor value
for the 50 ml assays using Rv1011 I was calculated to be 0.82.Identification of an Unknown Product
Interestingly, a product other than CDP-ME2P was produced,
apparently as the sole product, when the reaction mixtures9, December 24, 2009 ª2009 Elsevier Ltd All rights reserved 1233
ADefinition
Primers 
(Table 1)
Size 
(a.a.)
Solubility Activity
I ∆301-305 1&5 300 +++ +++
II ∆268-305 1&6 267 ++ ++
III ∆1-36 2&4 270 ++ -
IV
∆1-36, 
∆301-305
2&5 265 ++ +
V
∆1-36, 
∆268-305
2&6 230 + -
VI ∆1-88 3&4 215 +++ -
VII
∆1-88, 
∆301-305,
3&5 210 ++ -
VIII
∆1-88, 
∆268-305,
3&6 140 +++ -
B C
I
II
III
Rv1011
Homoserine Kinase Mof
GHMP Kinase Mof
1
36
88 268
301
Rv1011 I
Rv1011 II
Rv1011 III
Rv1011 IV
Rv1011 V
Rv1011 VI
Rv1011 VII
Rv1011 VIII
305
Figure 4. Identification of M. tuberculosis IspE and Purification Strategy
(A) Alignment of the amino acid sequence of E. coli IspE (ECO) and the putative IspE amino acids of M. tuberculosis (Rv1011) (MTB), B. mallei (BMA), S. Typhi
(STY), V. cholerae (VCH), and previously characterized Aquifex aeolicus (AAE) (Sgraja et al., 2008). Identities are highlighted in black and similarities in gray. The
amino acids reported to be involved in CDP-ME binding (I) and ATP-binding (II + III) reported in E. coli IspE (Miallau et al., 2003) are underlined.
(B) Rv1011 contains two predicted kinase motifs, a homoserine (ThrB) kinase (amino acids [aa] 36–301) and a GHMP Kinase (aa 88–268)]. A series of eight frag-
ments was engineered as indicated.
(C) Characteristics of the eight recombinant Rv1011 fragments. The primers used to amplify the fragments are listed in Supplemental Data S3. The solubility was
determined by using SDS-PAGE analysis and the activities were determined using the radioisotope based in vitro IspE assay. no; +, low; ++, intermediate; +++,
good.
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CDP-ME Kinase from Bacterial Pathogenscontained M. tuberculosis IspE or mSTE and Mn2+ or Zn2+
(Figure 6B). TLC analysis showed that the Rf value of the
unknown product is 0.34 and the amount of product generated
was proportional to the amount of Mn2+ or Zn2+ added to the
reaction mixtures (data not shown). Comigration experiments
of the unknown product with 2-C-methyl-D-erythritol 2,4-cyclo-
diphosphate (MECPP) showed that the Rf values of two products
were similar (Figure 6B), and the unknown product did not comi-
grate with authentic 2-C-methyl-D-erythritol diphosphate. Thus,
the data suggest that the new product could be MECPP.
However, reaction mixtures containing cytosolic fractions of
wild-type M. tuberculosis H37Rv without addition of exogenous
divalent cations produced only CDP-ME2P (Figure 6C), indi-
cating M. tuberculosis IspE only produces CDP-ME2P under
physiological conditions; therefore, the unidentified product
was not further characterized.1234 Chemistry & Biology 16, 1230–1239, December 24, 2009 ª2009DISCUSSION
M. tuberculosis IspD and IspF have previously been shown to be
essential (Buetow et al., 2007; Eoh et al., 2007), indicating that
the M. tuberculosis MEP pathway is vital for M. tuberculosis
growth (Sassetti et al., 2003). Although M. tuberculosis IspE
has been predicted to be essential (Sassetti et al., 2003), this
has yet to be formally demonstrated. Attempts were made to
demonstrate ispE essentiality inM. tuberculosis using previously
reported methods (Eoh et al., 2007; Parish and Stoker, 2000).
Of more than 140 single-crossover strains tested, none had
chromosomal ispE deleted, suggesting M. tuberculosis ispE is
essential for the bacillary survival. However, attempts to obtain
a chromosomal deletion in the merodiploid background (com-
plemented) were unsuccessful due to unidentified technical diffi-
culties, possibly a lack of site specific recombination in the ispEElsevier Ltd All rights reserved
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Figure 5. Biochemical Properties of M. tuberculosis IspE
(A) The optimal pH for catalytic activity was determined using MES (pH 5.5–
7.0), MOPS (pH 7.0–7.5), Tris (pH 7.5–8.5), TAPS (pH 8.5–9.0), and CAPS
(pH 9.0–10.5) using appropriate counter ions.
(B) Divalent cations (Mg2+, Mn2+, Zn2+, or Ca2+) were added to the reaction
mixtures at the indicated concentrations. The reaction mixtures were as
described in Experimental Procedures.
1      2      3 1     2    3     4
ATP
CDP-ME2P
1     2
B CA
MECPP
Unknown
Figure 6. TLC Analysis of the Product Generated by Rv1011 I
(A) The reaction mixtures containing CDP-ME, MgCl2, and [g-
32P]ATP without
Rv1011 I (lane 1) and with Rv1011 I (lane 2).
(B) Comigration experiment with a reaction containing [g-32P]ATP, CDP-ME,
and Rv1011 I in the presence of MnCl2 (lane 2) and a reaction containing
[g-32P]ATP, CDP-ME, Rv1011 I, and M. tuberculosis IspF (Eoh et al., 2009) in
the presence of MgCl2 (lane 3).
(C) Reaction mixtures containing CDP-ME and different amounts of wild-type
M. tuberculosis IspE. No (lane 1), 20 mg (lane 2), 40 mg (lane 3), and 60 mg (lane
4) of M. tuberculosis IspE were used. The migration positions of ATP, CDP-
ME2P, and MECPP are indicated by the arrows.
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CDP-ME Kinase from Bacterial Pathogenslocus. Therefore, M. smegmatis MSMEG_5436 (an ispE homo-
log) was utilized to confirm the essentiality of mycobacterial
IspE by an allelic disruption method, in that species. These
results strongly suggest that ispE is essential in M. tuberculosis
as was predicted (Sassetti et al., 2003).
Although the protein is predicted to be cytosolic, purification of
full-length native M. tuberculosis IspE was not possible under
any conditions tested, as reported previously (Sgraja et al.,
2008). Based on sequence alignments with orthologs from
E. coli and Aquifex aeolicus, which can be expressed as soluble
native enzymes, it is not clear why this should be the case;
however, this was also true for native IspE from the other patho-
gens studied here including B. malli, S. Typhi, and V. cholerae.
Truncation of the amino acids at N-terminal or C-terminal end
of M. tuberculosis IspE improved the solubility and retained
the activity of the expressed proteins. Notably, the truncated
version of M. tuberculosis IspE, Rv1011 I (Figure 4B), obtainedChemistry & Biology 16, 1230–123by removal of five amino acids (A-P-T-E-V) at the C terminus,
showed levels of activity comparable to those of wild-type IspE
found in M. tuberculosis cytosol.
Out of eight truncated versions ofM. tuberculosis IspE gener-
ated in this study, only three (Rv1011 I, II, and IV) showed IspE
activity, and only Rv1011 I and II, harboring intact ThrB, GHMP
kinase domains and N termini (amino acids 1–36), showed signif-
icant IspE activities, suggesting that the three conserved motifs
underlined in Figure 4A are critical for the activity. The first region
(K-L-N-L-F-L, of E. coli IspE) is reported to be involved in CDP-
ME binding (Miallau et al., 2003; Sgraja et al., 2008). The second
region (G-L-G-G-G-S, of E. coli IspE) and third region (L-T-G-
T-G, of E. coli IspE) constitute an ATP binding motif (Sgraja
et al., 2008; Miallau et al., 2003). The N-terminal region (amino
acids 1–36) of M. tuberculosis IspE is also reported to be
involved in forming CDP-ME binding domain (Miallau et al.,
2003). The five amino acids removed from M. tuberculosis IspE
overhang the C terminus of E. coli IspE in multiple alignments
(Figure 4A) and purified Rv1011 I showed IspE activity similar
to wild-type IspE. Therefore, the five amino acids at the
C terminus of M. tuberculosis IspE are relatively less critical for
activity but appear to be a major determinant for solubility of
heterologously expressed recombinant proteins. Soluble, active
IspE enzymes from B. mallei, S. Typhi, and V. choleraewere also
obtained by truncating five amino acids at the C terminus, even
though these amino acids do not align with each other, are not
conserved between the species and their removal does not
result in generation of a conserved C terminus.
The pH and divalent cation usage required for optimal activi-
ties of the bacterial IspE orthologs tested here are somewhat
different from those of previously reported for the A. aeolicus
IspE (Sgraja et al., 2008). The activities of four IspE orthologs
studied here were retained at acidic pH (5.5) and abolished at
basic pH (>10.0). However, the activity of A. aeolicus IspE was
very low at acidic pH (5.5–6.0) and retained at basic pH (9.0).9, December 24, 2009 ª2009 Elsevier Ltd All rights reserved 1235
Table 1. Calculated Kinetic Parameters for Bacterial IspE Orthologs
Source of IspE Substrates Km (mM) Vmax (mmol/min) kcat (S
1) kcat/Km (S
1mM1)
Wild type M. tuberculosis IspE CDP-ME 206.7 ± 12.5 2.4 N.A. N.A.
ATP 20.7 ± 1.2 2.0 N.A. N.A.
Rv1011 I (D301–305) CDP-ME 327.8 ± 21.4 2.8 480.1 1.5
ATP 75.2 ± 0.9 2.5 428.7 5.7
B. mallei IspE CDP-ME 31.3 ± 1.5 2.7 469.8 15.0
ATP 76.6 ± 1.1 2.4 417.6 5.5
S. Typhi IspE CDP-ME 25.4 ± 0.8 2.6 454.0 17.9
ATP 9.1 ± 0.2 2.1 366.7 40.2
V. cholerae IspE CDP-ME 52.9 ± 11.7 2.9 487.0 9.2
ATP 8.8 ± 1.3 2.1 352.7 40.1
The Km and Vmax values were calculated from averaged data from three independent experiments, using nonlinear regression analysis (SigmaPlot
V.8.02A). In the reaction mixtures, 97.2 pmol Rv1011 I, 95.5 pmol B. mallei IspE, 99.2 pmol S. Typhi IspE, and 95.8 pmol V. cholerae IspE were
used. N.A., not applicable.
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CDP-ME Kinase from Bacterial PathogensIn terms of divalent cation usage, Mg2+ at 6 mM supported
optimal IspE activity and concentrations higher than 10 mM
Mg2+ inhibited the IspE activity for all four species used here.
Divalent cations other than Mg2+ used in this study supported
significantly reduced IspE activity; Mn2+ allowed production of
CDP-ME2P at low concentrations and Zn2+ did not support
IspE activity (Figure 5B; Figure S5). Ca2+ supported mBME and
mVCE activities at concentrations below 25 mM. However,
Mn2+ supports A. aeolicus IspE activity at levels comparable to
Mg2+ (Sgraja et al., 2008). It should be noted that the character-
ization of A. aeolicus IspE was performed coupled to pyruvate
kinase and lactate dehydrogenase; therefore, the reported
effects of pH and divalent cations on A. aeolicus IspE may be
complicated.
The kinetic parameters obtained using Rv1011 I were compa-
rable to those of wild-type IspE inM. tuberculosis cytosolic frac-
tion (Table 1). The Km
CDP-ME value of Rv1011 I is similar to that
reported for E. coli (150 mM) (Bernal et al., 2005) and A. aeolicus
(121 mM) (Sgraja et al., 2008). The Km
CDP-ME values of mBME,
mSTE, and mVCE are similar each other, but are lower than
those reported for the IspE enzymes of E. coli, A. aeolicus and
Rv1011 I. The Km
ATP values for Rv1011 I and mBME are similar
but somewhat higher than Km
ATP values for mSTE and mVCE;
however, all four values are lower than those previously reported
for E. coli (420 mM) (Bernal et al., 2005) and A. aeolicus (222 mM)
(Sgraja et al., 2008). Although the Vmax and kcat values of IspE
enzymes from all four species studied here are similar, the
kcat/Km values were somewhat different depending upon the
origin of enzyme.
Rv1011 I and mSME produced an unknown compound in the
presence of Mn2+ or Zn2+, which has Rf value of 0.34 as deter-
mined by TLC analysis (Figure 6B). Previous reports indicates
that MECPP, the product of IspF, has an Rf value of 0.34 on
TLC in the same solvent system (Testa et al., 2006; Kishida
et al., 2003). Comigration experiments showed that new com-
pound has the same Rf value as MECPP (Figure 6B) although
the compound was not rigorously characterized. It is interesting
that IspEmay be able to generate MECPP fromCDP-MEwithout
producing CDP-ME2P under specific in vitro conditions. One
report predicted that CDP-ME2P is unstable and naturally hydro-1236 Chemistry & Biology 16, 1230–1239, December 24, 2009 ª2009lyzed (Kishida et al., 2003); however, the amount of the new
compound produced was proportional to the amount of added
Mn2+ or Zn2+ in our hands. It should be kept in mind that produc-
tion of this compound was not observed in reaction mixtures
containing wild-type IspE in cytosol and endogenous divalent
cations, suggesting that CDP-ME2P is the only product of
M. tuberculosis IspE under physiological conditions and that
the alternate activity is likely an artifact.
To date, characterization and crystallization of IspE from
bacterial pathogens have been hampered by a lack of substrate
and an inability to isolate a significant quantity of the enzyme.
These studies identified a way to obtain the soluble and active
IspE enzymes from bacterial pathogens. Moreover, we devel-
oped a fluorescence based IspE assay with an excellent
Z0-factor value, suggesting that this coupled assay is sufficiently
robust to screen for inhibitors. Thus, the results reported here
will allow development of HTS and facilitate elucidation of
crystal structures to aid in the identification of IspE specific
inhibitors.SIGNIFICANCE
An allelic disruption strategy was employed to confirm the
prediction that mycobacterial IspE is essential for bacterial
survival; in addition, this study provides first the character-
ization of IspE from pathogenic bacteria (M. tuberculosis,
B. mallei, S. Typhi, and V. cholera). A radiochemical based
assay was developed and utilized to directly identify the
enzymatic properties of IspE orthologs from the bacterial
pathogens. The fluorescence-based IspE assay provides
a facile and inexpensive HTS assay to screen for IspE
specific inhibitors. Because IspE is not targeted by any
current antimicrobial drugs, identification of IspE inhibitors
could contribute to disease control by providing leads to
new drugs for patients with multiple drug-resistant or
extensively drug-resistant tuberculosis or those infected
with other pathogenic bacteria. This study lays the ground-
work for structural-based studies of IspE from pathogenic
bacteria and HTS.Elsevier Ltd All rights reserved
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Materials
Genomic DNA and a cytosolic fraction isolated from wild-typeM. tuberculosis
H37Rv were provided by TB Vaccine Testing and Research Materials Contract,
Colorado State University (NIH NIAID N01-AI-40091). S. Typhi (700931D) and
V. cholerae (39315D) genomic DNA were purchased from the American Type
Culture Collection (ATCC, Manassas, VA). B. mallei genomic DNA was kindly
provided by Dr. Herbert Schweitzer (Colorado State University). All PCR
reagents and cloning materials were purchased from QIAGEN (Valencia,
CA). His-select nickel affinity resin, ATP, and reagents were obtained from
Sigma-Aldrich (St. Louis, MO). [g-32P]ATP (6000 Ci/mmol) and PD-10 columns
were purchased fromAmershamBiosciences (Pittsburgh, PA). The ADPQuest
HS Kinase Assay Kit was purchased from GE Healthcare Bio-Sciences Corp.
(Piscataway, NJ). All other reagents and solvents were of at least analytical
grade.
Synthesis of Enantiopure CDP-ME
Approximately 0.54 mmol tertiary alcohol 3 was dissolved in 10 ml freshly
distilled dry tetrahydrofuran (THF) and cooled to 0C. To the cooled solution,
1.08 mmol potassium hydride was added and stirred for 30 min at room
temperature. The reaction mixture was cooled to 0C again and 1.35 mmol
benzyl bromide was added slowly, warmed to room temperature, and stirred
for an additional 2 hr. The reaction was quenched by addition of saturated
ammonium chloride solution and extracted with ethyl acetate. The crude
mixture was purified by silica gel column chromatography using ethyl acetate:
hexane (7:3, v/v) as the solvent, yielding 0.486 mmol benzylated product (90%
yield) 4.
Data for 3: 1H-NMR (CDCl3, 300 MHz): d 7.34 (m, 10H), 5.78 (d, 1H, J =
3.6 Hz), 5.02-5.09 (m, 4H), 4.03-4.26 (m, 3H), 3.96 (dd, 1H, J = 2.7 & 7.8 Hz),
1.56 (s, 3H), 1.36 (s, 3H), 1.12 (s, 3H). 13C-NMR (CDCl3, 75 MHz):135.7,
135.6, 128.6, 128.5, 128.4, 128.0, 127.9, 112.7, 103.4, 83.9, 80.2, 76.1, 69.4,
69.3, 65.9, 26.5, 18.1.; IR (neat, cm-1): 3588, 2966, 2362, 2336, 1652, 1614.
HRMS (ESI) C23H30O8P (M+H
+): calculated 465.1673 and found 465.1680;
[a]D 33.0 (c 0.5, CHCl3).
Data for 4: 1H-NMR (CDCl3, 300 MHz): d 7.34 (m, 15H), 5.80 (d, 1H, J =
3.6 Hz), 5.02-5.07 (m, 4H), 4.54-4.67 (m, 2H), 4.08-4.35 (m, 4H), 1.60 (s, 3H),
1.37 (s, 3H), 1.20 (s, 3H). HRMS (ESI) C30H36O8P (M+H
+): calculated
555.5758 and found 555.5762 ; [a]D 13.0 (c 0.3, CHCl3).
For MEP and CMP coupling, 0.15 mmol CMP was dissolved in 1 ml aceto-
nitrile followed by addition of 0.6 mmol N,N, dimethyl aniline and 0.15 mmol
triethylamine at 0C. Then, 0.76 mmol trifluoroacetic anhydride in acetonitrile
was slowly added to the mixture and stirred for 15 min. Excess TFA and anhy-
dride was removed under reduced pressure. To the above reaction mixture,
a combination of 0.45 mmol 1-methyl imidazole and 0.76 mmol triethylamine
in acetonitrile was added slowly and stirred for 30 more min. The activated
CMP was added to the mixture of 0.125 mmol MEP and activated 4 A molec-
ular sieves in acetonitrile at 0C and stirred for 2 hr. After the reaction was
completed, the mixture was extracted with chloroform and the aqueous
layer was lyophilized. CDP-ME was purified by sequential chromatography
on a Bio-Gel P-2 gel fine column using 100 mM aq. ammonium bicarbonate
followed by further purification on a benzyl DEAE cellulose anion exchange
column, using a gradient of 0 to 0.5 M aq. ammonium bicarbonate solution.
This resulted in a 45% yield of CDP-ME.
Data for CDP-ME: 1H-NMR (D2O, 300 MHz): d 7.94 (d, 1H, J = 7.5 Hz), 6.09
(d, 1H, J = 7.5 Hz), 5.96 (d, 1H, J = 4.2 Hz), 4.27 (m, 6H), 3.95 (m, 1H), 3.80
(d, 1H, J = 10.5 Hz), 3.57 (d, 1H, J = 11.7 Hz), 3.44 (d, 1H, J = 11.7 Hz), 1.10
(s, 3H). HRMS (ESI) C14H25O14N3P2 (M-H
+) calculated 520.0728 and found
520.0724; [a]D 13.7 (c 0.2, H2O).
Construction of Vectors for the Determination of Mycobacterial
IspE Essentiality
Initially, attempts were made to demonstrate ispE essentiality in M. tubercu-
losis using previously reported methods (Eoh et al., 2007; Parish and Stoker,
2000); however, attempts to obtain a chromosomal deletion in the merodiploid
background (complemented) were unsuccessful, due to unidentified technical
difficulties. Thus, we utilized allelic disruption to demonstrate essentiality in the
related species,M. smegmatis. The construction ofM. smegmatis ispE ortho-Chemistry & Biology 16, 1230–123log (MSMEG_5436) replacement plasmid (pPR27::Sm ispE::KanR) and
a rescue plasmid (pCG76-Sm ispE) is illustrated in Figure 3A. Briefly, a 2849
bp DNA fragment containing M. smegmatis ispE ortholog (MSMEG_5436),
940 bp upstream, and 940 bp downstream of the gene was amplified by
PCR using the MutSmispE-F and R (Table S3). The DNA fragment was
cloned to pGEM T plasmid and a 1250 bp Kan resistance cassette (KanR)
was cut out with HincII from plasmid pUC4K, and inserted into the Klenow
fragment (Invitrogen)-filled RsrII site of the MSMEG_5436 gene. A 2849 bp
SM ispE::KanR fragment was cut by SpeI and XbaI and moved to the same
enzyme site of pPR27 (temperature-sensitive mycobacterial origin of replica-
tion; sacB, xylE, gentamicin resistant) (Pelicic et al., 1997), yielding pPR27::SM
ispE::KanR, the vector used to achieve homologous recombination event
at the SMEG_5436 locus of M. smegmatis. The pPR27 used in this study
has the mycobacterial temperature-sensitive origin of replication. Thus,
pPR27::SM ispE::KanR can replicate at 32C but is efficiently lost at 42C
and above (Pelicic et al., 1997; Pan et al., 2001). In addition, the plasmid
also contains the counterselectable marker sacB from Bacillus subtilis (Pelicic
et al., 1997) for use in selection of the double-crossover event in the presence
of sucrose.
The entireM. smegmatis MESG_5436 genewas amplified by PCRwith using
primer set (SmispE-F and R) (Table S3) and cut with NdeI and BamHI and
ligated into the same enzyme sites downstream of the heat shock promoter
Phsp60 in plasmid pCG76 (E. coli/Mycobacterium shuttle vector carrying
a temperature sensitive origin of replication, and streptomycin resistance),
yielding pCG76::SM ispE (Figure 3A). Plasmid pCG76 carries the same
temperature-sensitive mycobacterial replication origin as pPR27, and thus
can replicate at the permissive temperature of 32C but is abrogated at
42C and above (Jackson et al., 2000).
PCR Amplification of Putative ispE Orthologs of M. tuberculosis,
B. mallei, S. Typhi, and V. cholerae
Homologs of E. coli IspE from the genomes of bacterial pathogens were iden-
tified by sequence alignment. The M. tuberculosis H37Rv genome is available
on the Tuberculist website (http://genolist.pasteur.fr/Tuberculist) and other
three bacterial genome sequences are available on the GenBank of National
Center for Biotechnology Information (NCBI) website (http://www.ncbi.nlm.
nih.gov/Genbank/). The DNA sequences were used to design oligonucleotides
for amplification of putative ispE open reading frames. The PCR primers
(Table S3) were designed to contain NdeI or HindIII restriction enzyme sites
in the forward and reverse primers, respectively.
Cloning of Eight M. tuberculosis ispE Fragments
Purification of the native form of the putative M. tuberculosis IspE (Rv1011)
proved difficult as reported previously (Sgraja et al., 2008); however, soluble
M. tuberculosis IspE was obtained by removal of amino acid residues at either
the N terminus, C terminus, or both termini. Genetic modifications were
designed using conserveddomain searches forM. tuberculosis IspE as aquery
performed by tools available in the NCBI (specialized BLAST) (Figure 4B). The
PCR products of eight Rv1011 fragments were amplified using the primer sets
shown in Table S3. For amplification of Rv1011 fragments I through VIII
(Figure 4B), primers were designed based on the sequences available in
TubercuList (Table S3) and were synthesized by Macromolecular Resources
(Colorado State University). The eight amplified PCR products were digested
withNdeI andHindIII, and ligated into the pET28a(+) vector (EMD Biosciences,
Inc., San Diego, CA). The ligation mixtures were used to transform the E. coli
DH5a cloning host (Life Technologies, Rockville, MD), generating DH5a
[pET28a(+):: Rv1011 I] through DH5a[pET28a(+):: Rv1011 VIII]), which were
subsequently purified using Gene Extraction Kits (QIAGEN, Valencia, CA)
and sequenced by Macromolecular Resources.
Cloning of Truncated ispE Orthologs of B. mallei, S. Typhi,
and V. cholerae
Forward and reverse primers for amplifying ispE of B. mallei, S. Typhi, and
V. cholerae were designed to remove the five C-terminal amino acids
(Table S3), resulting in generation of three truncated versions of bacterial
IspE enzymes. Expression constructs, pET28a(+)::mBME, pET28a(+)::mSTE,
and pET28a(+)::mVCE were generated as described above.9, December 24, 2009 ª2009 Elsevier Ltd All rights reserved 1237
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CDP-ME Kinase from Bacterial PathogensExpression and Purification of the Recombinant Proteins
Recombinant Rv1011 I through VIII, mBME,mSTE, andmVCEwere expressed
and purified as previously described (Eoh et al., 2007; Mao et al., 2008). Briefly,
transformation of expression E. coli host, BL21(DE3) (Novagen, Madison, WI),
with expression plasmids afforded the recombinant strains, BL21(DE3)
[pET28a(+)::Rv1011 I] through BL21(DE3)[pET28a(+)::Rv1011 VIII], BL21(DE3)
[pET28a(+)::mBME], BL21(DE3)[pET28a(+)::mSTE], and BL21(DE3)[pET28a(+)::
mVCE]. Cells were grown to an OD600 of 0.6, treated with 0.5 mM isopropyl-b-
D-thiogalactopyranoside at 20C for 16 hr, harvested by centrifugation, resus-
pended in binding buffer [50 mM 4-morpholine propane sulfonic acid (MOPS)
(pH7.9), 1mMMgCl2, 10%glycerol, and 1mM b-mercaptoethanol], anddisrup-
ted by sonication using a Sanyo Soniprep 150 (Integrated Services, TCP Inc,
Palisades Park, NJ) on ice. The recombinant proteins carrying hexa-His tags
werepurifiedby immobilizedmetal affinity chromatographyusingaNi-NTA resin
(Sigma-Aldrich,St. Luis,MO)andanalyzedbySDS-PAGEandwesternblot anal-
ysis with using an anti-His antibody (Sigma-Aldrich). Fractions containing pure
recombinant protein were desalted using PD-10 columns and concentrated
using a 5000 molecular weight cutoff Centricon (Millipore, Bedford, MA).In Vitro Radiochemical IspE Assay
For enzymatic characterization, IspE assays were performed in reaction
mixtures containing 50 mM Tris-Cl (pH 7.0), 100 mM [g-32P]ATP (100 dpm/
pmol), 2 mM DTT, 100 mM CDP-ME, and 5 mM MgCl2 in a 50 ml final reaction
volume. Reactions were initiated by addition of recombinant IspE (97.2 pmol
Rv1011 I, 95.5 pmol mBME, 99.2 pmol mSTE, and 95.8 pmol mVCE), incu-
bated at 37C for 30 min, and terminated by the addition of 10 mM of EDTA
(pH 8.0). TLC analysis was performed by transferring 10 ml reaction mixture
to a TLC plate (Polygam Sil N-HR, Macherey and Nagel) and developing
with n-propanol/ethyl acetate/H2O (6:1:3,v/v/v). Location and quantitation of
radiolabeled products on the TLC plates was determined by using aMolecular
Dynamics Typhoon 8600 Phosphoimager.Fluorescence-Based IspE Assay
For HTS purposes, ADP released from the IspE catalyzed reaction was
coupled to commercially available the ADP Quest HS Kinase Assay Kit con-
taining pyruvate kinase, pyruvate oxidase, and horseradish peroxidase, to
produce a fluorescent dye (resorufin). The reaction mixtures, containing
50 mM Tris-Cl (pH 7.0), 100 mM ATP, 100 mM CDP-ME, 5 mM phosphatase
inhibitor (Roche Bioscience, Palo Alto, CA), 5 mM MgCl2, and 97.2 pmol
Rv1011 I in a 50 ml final reaction volume in 96 well black microplates with clear
bottom (Costar, NY), were incubated at 37C for 30 min. Then, 25 ml reagent
A and 50 ml reagent B (ADP Quest HS Kinase Assay Kit) were added, sequen-
tially. After incubating for another 15 min at room temperature, fluorescence
was measured using a SynergyTMMulti-Detection Microplate Reader (BioTek
instruments) at an excitation wavelength of 530 nm and emission wavelength
of 590 nm.Determination of Z0-Factor Value
Z0-factor values for fluorescence-based IspE assays were determined as was
previously reported (Zhang et al., 1999). All steps of the assay were performed
using an automated fluid transfer system (Precision XS microplate sample
processor, BioTek instruments) in 96 well microplates. A total of 96 assays
were performed for both positive (with enzyme) and negative controls (without
enzyme).Enzymatic Properties
The effect of ATP concentration on IspE activity was determined using
a constant concentration of CDP-ME (100 mM) and varying concentrations of
ATP. The effect of CDP-ME concentration was determined using a constant
concentration of ATP (100 mM) and varying concentrations of CDP-ME. The
Km and Vmax values of substrates for the enzyme were calculated using non-
linear regression analysis (SigmaPlot V.8.02A). To determine the pH optima
of Rv1011 and IspE orthologs, appropriate buffers (MES, MOPS, Tris, TAPS,
or CAPS) were used. Optimal concentrations for divalent cations were deter-
mined in assay mixtures containing MgCl2, CaCl2, ZnCl2, or MnCl2 at the indi-
cated concentrations.1238 Chemistry & Biology 16, 1230–1239, December 24, 2009 ª2009Characterization of an Unknown Product Generated
by M. tuberculosis IspE
The mobility of the unknown product and M. tuberculosis 2-C-methyl-D-
erythritol 2,4 cyclodiphosphate (MECPP) on TLC plates was also compared.
Authentic MECPP was obtained by enzymatic synthesis in reaction mixtures
containing Rv1011 I, CDP-ME, [g-32P]ATP, and 112.6 pmol recombinant
M. tuberculosis IspF (Rv3581c) (Eoh et al., 2009), which had been incubated
at 37C for 30 min.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, three
figures, and one table and can be found with this article online at http://
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